Watervein Partners

HOME

What is Watervein Partners?

THE TEAM

ADVISORS

How business is created?

AUG.21(FRI),2009 Anaeropharma is interviewed. See News

MAY.21(TEU),2009 Moved to new office

FEB.09(FRI),2007 A new portfolio company, Interprotein

JUN.20(THU),2006 One of the portfolio companies changed its name

MAY.19(THU),2005 A new portfolio company, CellGentech

MAR.02(WED),2005 A new portfolio company, RT Solutions

DEC.14(THU),2004 Watervein has completed a final closing of its venture fund.

Sep.30(THU),2004 Watervein made an investment into Anaeropharma Science.

APR.01(THU),2004 SITE OPEN

May. 2009

Watervein has moved to a new office. Please see CONTACT for more information.

Dec. 2004

Watervein Partners has completed a final closing of its first venture fund named Watervein Technology Investment Fund I. With 2.3 billion yen total capital available to deploy against next generation start-up biotech ventures, the fund now has sufficient resources to continue actively investing through the end of 2013.

JAN. 2004

Watervein Partners raised a 2 billion yen biotech venture fund. The firm's first fund, named Watervein Technology Investment Fund I, will not only invest into biotechnology, medical and life science based start-up ventures, but also will provide them with thorough hands-on. The main investor in the fund is Development Bank of Japan, and the remainders are including Alternative Investment Capital (AI Capital; a joint co of Mitsubishi Corp. and Daido Life Insurance), Tokyo Medium and Small Business Investment Consultation (Tokyo SBIC), SMBC Capital, Fuso Pharmaceutical Industries, Mitsubishi Corp. and UFJ Bank.